Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Lapsed on 27 August 2020) Salbutamol 2.5mg/2.5mL Nebuliser solution (Breath Limited)
Section 19A approved medicine
(Lapsed on 27 August 2020) Salbutamol 2.5mg/2.5mL Nebuliser solution (Breath Limited)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Lapsed
Medicines in short supply/unavailable
VENTOLIN NEBULES salbutamol 2.5mg/2.5mL (as sulfate) inhalation solution ampoule - ARTG 12533
Indication(s)
For the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease.